C.H. Robinson (CHRW) › Analysis

C.H. Robinson (CHRW) stock analysis, November 3, 2026: Strong earnings fail to stop a weekly downtrend

Published November 3, 2026 · CHRW chart, levels and live analysis

C.H. Robinson Worldwide (CHRW) reported third-quarter profit growth of more than 20%, yet the stock has lost about 16% in a month and trades at $131.94, just above its 52-week low. The weekly trend is down, the daily trend runs with it, and the shares are lagging the S&P 500. The balance of evidence for the next two to six weeks leans negative, with medium conviction (2 of 4 points).

Why it matters

The business news was good. Third-quarter revenue rose 29.5% to $5.4 billion, driven by higher pricing in truckload, ocean and LTL, according to the Motley Fool transcript. Net income rose 21.8% to $198.5 million, and adjusted earnings per share rose 28.6% to $1.80. The 10-Q filing confirmed diluted EPS of $1.67, up 25%. A stock does not usually sell off after numbers like these unless the market was already pricing something better, or doubts that the pricing-driven growth will last.

The price action says the market did not reward the quarter. The shares peaked at $157.72 on October 2, 2026 and have since fallen 16.3%. Over the last five days they are down 8.1%, against 2.1% for the S&P 500 (SPY). The market explains part of that drop, but the stock fell about four times as far, so most of it is specific to CHRW. No sector fund comparison is available. On October 30, 2026, Bank of America removed CHRW from its U.S. 1 List while keeping its Buy rating, which may have added to the selling. That is a plausible contributor, not a full explanation. A law-firm notice on November 3, 2026 that names RXO among four proposed mergers touches a freight peer, but says nothing about CHRW itself.

The sector backdrop is mixed. The Zacks transportation group expected third-quarter earnings up 9.6% year over year, but Delta Air Lines opened the season with a miss on fuel and non-fuel costs. Cost pressure across transport is a reasonable worry for a company whose growth leans on pricing.

No articles in the feed argue the case for or against CHRW, so the debate shows up in the analyst numbers. Twenty-three analysts rate the stock a consensus buy, with a mean price target of $179.30 and a range from $131 to $235. The price sits 26.4% below the mean, and the lowest target is almost exactly where the stock trades. The optimistic case is that earnings are growing quickly and the shares are priced as if they are not. The cautious case is that the market is ignoring that growth because it expects the pricing lift to fade.

What the evidence says

On the long term, the earnings thesis is intact but the price trend is broken. The stock is below its 40-week average, and the 50-day average ($144.80) sits well under the 200-day ($169.08). The shares are 37% below their 52-week high of $209.42 and down 25.6% over six months. They are down 17.9% this year while SPY is up 10.5%. This looks like a late markdown phase in which sellers still control the weekly chart, and the 52-week low of $124.61 is only 5.9% below the current price.

For the next two to six weeks, the evidence leans negative. Conviction is medium, with 2 of 4 points. Two things support that reading: the daily trend runs with the weekly downtrend, and the stock lags the S&P 500 by 7.3% over 50 days (24.9% over 200 days). The strongest case against it is today's 2.5% bounce, an RSI of 41.6 that shows the stock is not yet oversold, and results that would normally support a higher price. The bounce is coming on volume running 57.7% below its 20-day average, so few buyers are taking part. A rebound of this kind has not changed the weekly trend, and the lack of confirmation from the other two points is why conviction is medium and not higher.

Levels that matter

The structure sits below $132.49, a swing zone where sellers have appeared on earlier rallies. The price is right at it now. The trend would end only on a weekly close above $143.64, another swing zone, and that level also sits just under the 50-day average at $144.80. Higher resistance sits at $149.42 and $150.

The breakout level is a daily close below $125.00, a round number just above the $124.61 low. From there the next marked level is $100, which gives a reward-to-risk of 2.8 to 1 against a stop at $133.94 (the $132.49 zone plus a quarter of the 14-day average true range). That does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target below $100 or a tighter stop than $133.94 to get there.

What would change the picture

A weekly close above $143.64 would be the first sign that buyers are back and that the downtrend is over. The non-price fact that could drive it is evidence that earnings growth holds as pricing gains fade, which would mean the third-quarter profit growth was not just a one-quarter lift. A next-quarter result that holds or beats the $1.80 adjusted EPS would be that evidence.

What to watch

Get a message when the CHRW picture changes — the agent team watches the levels and the news for you.Create a free account

More CHRW analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.